LATEST ALERTS
Food
Despite industry investment, the future remains cloudy for cannabinoid drinks
20th January 2022 - Blogs , News analysis |
Covid has significantly increased consumer interest in health and wellness, with food and drink formulations that create innovative solutions for “mental and emotional wellbeing” becoming a 2021 trend
Regulatory report: Slovenia, December 2021
2nd December 2021 - Regulatory reports |
Slovenia’s stance on CBD in the light of the Kanavape case isn’t clear; recreational cannabis rules not likely change; medicinal cannabis rules might change
Novel food process ‘has trapped Britain’s CBD industry in a frustrating limbo’
2nd December 2021 - News analysis |
A market that cannot innovate stagnates – and that is exactly what is happening with CBD in the UK because of delays in the novel food application process which mean companies cannot introduce any new products
The suspense continues, still with no end in sight to the UK’s novel food saga
3rd November 2021 - Blogs , News analysis |
October has ended and November begun with still no further update from the UK Food Standards Agency (FSA) on the ongoing novel food application process
Is CBD a dietary ingredient or a drug? US FDA ‘appears to have changed its mind’
13th October 2021 - News analysis |
The lack of a clear regulatory pathway to market for CBD products in the US is highlighted by a row over the FDA’s denial of new dietary ingredient (NDI) approval for full spectrum hemp extracts
From craft beer to coffee, patience is a virtue in cannabinoid beverages
4th October 2021 - News analysis |
Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens
What does the recent USPTO trademark decision mean for the industry?
22nd September 2021 - Blogs , News analysis |
The USPTO Appeals Board verdict upholding the USPTO’s decision to not grant Joy Tea a trademark covering CBD beverages should come as no surprise
Lidl has a change of heart, removing edible hemp products from its shelves
21st September 2021 - News analysis |
Discount supermarket chain Lidl has removed foods containing hemp from its stores in Germany, Ireland and the Netherlands amid concerns that the products contain excessive levels of THC
Beverage brands still searching for the right solution to their drink problem
9th September 2021 - Blogs , News analysis |
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD to be used as an ingredient for a beverage or any other ingestible product. And there is growing concern that – given » Continue Reading.
British chef brings two-star Michelin expertise to US CBD beverage market
6th September 2021 - News analysis |
Two-star Michelin expertise is coming to the US CBD sector with the advent of a new CBD beverage with flavours developed by British chef Michael Caines
Growing cannabis drinks market may be a case of keeping up with the Joneses
27th August 2021 - News analysis |
Cult favourite Jones Soda will enter the US cannabis beverage market, while an Oklahoma firm’s new beverage launch looks well positioned to capitalise on any move to a recreational market in the state
And now for our next Trip, let’s head for the US with $5m spending money
29th June 2021 - News analysis |
CBD-infused drinks company Trip is making its way into the US after it raised $5m (£3.6m) in a Series A funding round last month
The Future of CBD in Europe post novel food regulations
12th May 2021 - Presentations , Resources |
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as well as discussion around how » Continue Reading.
UK FSA releases initial validated novel food application list
23rd April 2021 - News analysis |
The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released
How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?
22nd April 2021 - Blogs |
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.
Mixed feelings as UK industry sees pros and cons in FSA switch on novel foods
25th March 2021 - News analysis |
Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding
UK Food Standards Agency relaxes the rules slightly on novel food submissions
15th March 2021 - News analysis |
Companies now only to have submitted an application to the UK Food Standards Agency (FSA) in order for their edible CBD products to stay on the market after 1st April
Silent Pool ‘unimpressed’ by Portman Group code violation ruling
26th February 2021 - News analysis |
CBD-infused gin manufacturer Silent Pool remains defiant after drinks industry regulatory body the Portman Group ruled that its Colorado High product was in violation of its code
Molson Coors and Hexo joint venture Truss launches CBD beverage in US
15th January 2021 - News analysis |
Molson Coors and Hexo joint-venture Truss has finally released its CBD beverage in the US state of Colorado.
The long wait goes on for a successful European novel food application
28th December 2020 - News analysis |
Officials from the European Commission (EC) met with CBD-Intel to discuss the status of novel food applications in light of the ruling in the Kanavape case
Newer brands perform better in labelling accuracy for edibles, report finds
30th November 2020 - News analysis |
More established brands performed worse than their new upstart rivals in the latest report on CBD labelling accuracy
A comparative analysis of state laws in the US
19th November 2020 - Presentations , Resources |
Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now watch her presentation to obtain » Continue Reading.
The cannabinoid drinks market is getting crowded – but it still takes a lot of bottle
19th November 2020 - News analysis |
Current lack of success in Canada and unsupportive regulations in the US have not stopped cannabinoid companies from exploring the beverages sector
Italian health ministry suspends its decree defining oral CBD as medication
6th November 2020 - News analysis |
The Italian Ministry of Health has suspended the recently published decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law
UK novel foods committee provides food for thought on white-label ingredients
6th November 2020 - News analysis |
Concerns over traceability, limiting final use and demonstrating safety of final products could make it difficult to grant UK novel food approval to CBD ingredients producers and white label manufacturers
What impact could a decision in the recent Dusseldorf lawsuit have on the German CBD sector?
23rd October 2020 - Blogs |
The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing CBD
What impact will the US elections have on CBD and cannabis?
16th October 2020 - Blogs |
It’s important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation efforts
Red yeast rice and stem cells could point the way ahead for FDA regulation of CBD
16th October 2020 - News analysis |
The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD
Do companies need toxicological study data included in UK Food Standards Agency (FSA) novel food applications for them to be validated?
9th October 2020 - Blogs |
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
German city’s ban on foods containing natural CBD extracts faces legal test
7th October 2020 - News analysis |
A decision by the German city of Düsseldorf to prohibit the sale of all foods containing CBD, including in natural extract form, faces a legal challenge from local hemp wholesaler Hempro International
Ale and hearty – a new CBD food and drinks trade springs up in Hong Kong
23rd September 2020 - News analysis |
2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products
Podcast: what can European markets do with CBD Novel Food applications?
2nd September 2020 - Podcasts , Resources |
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
Molson venture launches but ingestibles may be seeing less success
28th August 2020 - News analysis |
Molson Coors has made its long awaited entry into the cannabis market through the launch of its Truss brand of cannabis drinks made in partnership with cannabis company Hexo
Worse delays feared for European CBD novel food authorisations
27th August 2020 - News analysis |
Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns
Charlotte’s Web denied US trademark on appeal ‘because CBD oil isn’t legal’
26th August 2020 - News analysis |
Charlotte’s Web has been denied a US trademark on appeal – a ruling that has serious implications for any company in the CBD sector selling food, drink or dietary supplement products in the US
German firm waits to hear whether new CBD oil will be deemed ‘novel food’
24th August 2020 - News analysis |
A German company is still waiting to hear from the authorities two months after launching new CBD products that could be considered food supplements
What can be made of Canopy’s increased interest in functional ingredients?
21st August 2020 - Blogs |
Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share.
Canopy Growth takes stride into sports nutrition with NFL superstar tie-up
19th August 2020 - News analysis |
Canadian cannabinoid firm Canopy Growth has signed a multi-year deal with NFL quarterback Patrick Mahomes as part of its advance into the sports nutrition market
Why does the European Commission (EC) think CBD may be a narcotic?
14th August 2020 - Blogs |
The opinion (which is not yet set by the EC but appears to be the way the organisation is thinking) is based on a literal reading of the 1961 UN Narcotics Convention.
What can we expect from the US Food and Drug Administration (FDA) proposals to regulate CBD under review by the White House Office of Management and Budget (OMB)?
7th August 2020 - Blogs |
Authorities have been very tight lipped about the details of the proposed regulations and little is known beyond the title of the document.
Now that Swiss authorities have returned taxes, what is the industry planning to do?
31st July 2020 - Blogs |
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
What are CBD-Intel’s thoughts on the EC’s position regarding CBD potentially being a narcotic?
24th July 2020 - Blogs |
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
CBD drinks company reaps the benefits of TV advertising campaign
20th July 2020 - News analysis |
A TV advertising campaign has significantly boosted sales for a CBD drinks company and it hopes a new listing in a high-end chain of UK supermarkets will consolidate those gains
What implications can be drawn from the recent decision on Indiana’s smokable hemp ban?
17th July 2020 - Blogs |
Although opponents of the ban had their positive result overthrown by the Seventh Circuit Court of Appeals, the decision is not as bad as a headline might suggest.
Now that novel food applications in Europe are delayed, what does enforcement look like?
10th July 2020 - Blogs |
Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC’s questions over whether CBD constitutes a narcotic under the 1961 UN Single Convention on Narcotics.
How is the novel food status of CBD progressing in Europe?
3rd July 2020 - Blogs |
Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.
EIHA launches novel food application consortium project
26th June 2020 - News analysis |
A new consortium project from the EIHA will put four separate novel food applications in to European and UK authorities after performing the necessary toxicological and safety studies
UK FSA provides further guidance for novel food application requirements
26th June 2020 - News analysis |
The UK Food Standards Agency (FSA) has provided further guidance on when a CBD product would need to have a separate or new novel food authorisation
EC takes time out on novel food to decide if CBD is legally a narcotic
24th June 2020 - News analysis |
Progress on novel food authorisations for non-synthetic cannabinoids will be paused until European regulators decide whether extracts from hemp flowers constitute a drug under narcotics laws, CBD-Intel has learned
